Amylin Pharmaceuticals is an exceptional company of extraordinary people. Their willingness to challenge conventional thinking as much as they challenge themselves, their resolve, resiliency and passion for the patient are improving the lives of millions.

The men and women of Amylin are discovering, developing, and bringing to market innovative therapies with life-changing potential for people struggling with diabetes and obesity—merging epidemics that are fast becoming the major health crises of our lifetime. In the process, they are building an exciting new franchise in the treatment of metabolic disease and a pipeline of possibilities for future healthcare solutions.

---

Building Blocks

The two building blocks upon which Amylin was founded-Challenging Science and Changing Lives-remain the cornerstone of our mission today. We hope this blog will serve as an additional means to convey our passion for protein and peptide science, and the potential of harnessing these molecular "building blocks" to treat metabolic diseases, and further our dedication to improving patients' lives.

To learn more, visit the Building Blocks website.

---

News & Events